PHAT
PHAT
NASDAQ · Pharmaceuticals

Phathom Pharmaceuticals Inc

$7.48
-0.27 (-3.48%)
As of Sep 20, 10:16 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +578.3% upside
Low Target $34.41
Average Target $50.74
High Target $70.04
Current Price $7.48
Current
$7.48
Target
$50.74
$34.41 $50.74 avg $70.04
Scenario Analysis
Bear Case
$34.41
360.0%
Low target
Base Case
$50.74
+578.3%
Avg target
Bull Case
$70.04
+836.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$18.31
-59.1% from high
52-Week Low
$7.59
+-1.4% from low
Target vs 52W High
$50.74
+177.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%